No Data
The price of Vitamins D3 has surged! The Sector responded with a breakout, and Hunan Er-kang Pharmaceutical hit the 20% limit up.
Institutions: It is expected that the domestic Vitamins share will continue to increase.
Qianjiang Yongan Pharmaceutical (002365.SZ): has not yet conducted online direct sales or authorized sales through cross-border e-commerce platforms.
Glonghui, April 17th, Qianjiang Yongan Pharmaceutical (002365.SZ) stated on the interactive platform that the sales model for its product taurine combines sales through agents and direct sales to end customers. Currently, it has not conducted direct online sales or authorized sales through cross-border e-commerce platforms.
Qianjiang Yongan Pharmaceutical Co., Ltd.'s (SZSE:002365) Shares Climb 26% But Its Business Is Yet to Catch Up
Yongan Pharmaceutical: 2024 Annual Report Summary
Yongan Pharmaceutical: 2024 Annual Report
Qianjiang Yongan Pharmaceutical (002365.SZ): The net income for the 2024 fiscal year is 61.766 million yuan, proposing a dividend of 1 yuan per share.
On April 9, Gelonghui reported that Qianjiang Yongan Pharmaceutical (002365.SZ) announced its annual report for 2024, achieving revenue of 0.839 billion yuan, a year-on-year decrease of 13.78%; the Net income attributable to shareholders of the listed company was 61.766 million yuan, turning profitable year-on-year; the Net income attributable to shareholders of the listed company after deducting non-recurring gains and losses was 26.7581 million yuan; EPS was 0.2107 yuan; a cash dividend of 1 yuan (tax included) will be distributed for every 10 shares to all shareholders.
Benign Growth For Qianjiang Yongan Pharmaceutical Co., Ltd. (SZSE:002365) Underpins Stock's 27% Plummet
